Verastem, Inc. (VSTM)
4.405
-0.30
(-6.48%)
USD |
NASDAQ |
May 15, 12:56
Verastem Shareholders Equity (Quarterly) : 81.78M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Altimmune, Inc. | 283.99M |
| Ocugen, Inc. | 5.805M |
| BioXcel Therapeutics, Inc. | -95.46M |
| Xilio Therapeutics, Inc. | 72.54M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 227.81M |
| Total Liabilities (Quarterly) | 146.03M |
| Debt to Equity Ratio | 1.045 |
| Current Ratio | 3.035 |
| Net Debt Paydown Yield | -1.86% |